4.67
price down icon6.22%   -0.31
after-market Dopo l'orario di chiusura: 4.71 0.04 +0.86%
loading

Candel Therapeutics Inc Azioni (CADL) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
18.16%
13.21
11.18 8.13 8.757 8.571
Interest Income/Expense
31.78%
0.161
0.236 0.306 0.487 0.567
Operating Income/Loss
18.16%
-13.21
-11.18 -8.13 -8.757 -8.571
Nonoperating Income/Loss
69.63%
1.938
6.381 15.51 -1.889 -13.67
Income/Loss From Continuing Operations Before Tax
134.97%
-11.27
-4.796 7.379 -10.65 -22.24
Income/Loss From Continuing Operations After Tax
134.97%
-11.27
-4.796 7.379 -10.65 -22.24
Net Income/Loss
134.97%
-11.27
-4.796 7.379 -10.65 -22.24
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
6.61%
54.89
51.49 50.48 32.01 29.88
Diluted Average Shares
6.61%
54.89
51.49 54.77 32.01 29.88
Basic Earnings Per Share
133.33%
-0.21
-0.09 0.15 -0.33 -0.74
Diluted Earnings Per Share
133.33%
-0.21
-0.09 0.13 -0.33 -0.74
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):